Skip to content

ClinPOC TB

Clinical scoring tool for point-of-care diagnosis of tuberculosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201611001838365
Enrollment
3600
Registered
2016-10-29
Start date
2016-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Enhanced usual care
TBscore

Sponsors

Novo Nordisk Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All adult patients aged >15 years Cough (regardless of duration) and/or weight loss and/or expectoration.

Exclusion criteria

Exclusion criteria: TB treatment within the past year. Patients with cerebral disturbances that complicates the ability to give informed consent or follow the treatment regime.

Design outcomes

Primary

MeasureTime frame
) Increase in diagnostic yield of active TB compared to baseline and control EUC clinics and time to diagnosis compared to standard care.

Secondary

MeasureTime frame
) Effect on treatment outcomes (for TB diagnosed patients) and all cause mortality 12 month after first encounter (for all included).;Usability of the Bandim TBscore at points of healthcare.;Diagnostic yield as of sputum smear microscopy (smear positive cases) and as of chest x-ray and antibiotic treatment/ GenXpert (smear negative cases).;To further strengthen the trial capacity built under EDCTP1 at sites in Guinea Bissau and Ethiopia.

Countries

Ethiopia, Guinea-Bisseu

Contacts

Public ContactFrauke Rudolf
frauke.rudolf@clin.au.dk+4551372359

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026